Skip to main content
ONCIMMUNE HOLDINGS PLC logo

ONCIMMUNE HOLDINGS PLC — Investor Relations & Filings

Ticker · ONC ISIN · GB00BYQ94H38 LEI · 213800HCYIWT6YPI1I02 IL Professional, scientific and technical activities
Open in API
Filings indexed 362 across all filing types
Latest filing 2019-10-16 Regulatory Filings
Country GB United Kingdom
Listing IL ONC

About ONCIMMUNE HOLDINGS PLC

https://www.oncimmune.com/

Oncimmune Holdings PLC is a precision medicine and immunodiagnostics company specializing in the discovery and application of antibody and autoantibody biomarker signatures. The company's core technology is the ImmunoINSIGHTS™ platform, an advanced analytical engine for immune profiling. This platform utilizes a proprietary library of over 9,000 human antigens, bead-based multiplexed immunoassay technology, and machine learning algorithms to generate biological insights from minimal sample volumes. Oncimmune applies its expertise across therapeutic areas including immuno-oncology, autoimmune diseases, and infectious diseases. It provides biomarker discovery services, targeted panels, and advanced bioinformatics to support pharmaceutical and biotechnology partners in developing more effective and targeted treatments and diagnostics.

Recent filings

Filing Released Lang Actions
Oncimmune welcomes NHS review of cancer screenings
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory announcement disseminated via the London Stock Exchange's news service (RNS). The content discusses the company's reaction to the publication of an independent review regarding NHS cancer screening programs and highlights the utility of their EarlyCDT Lung test. It is not a full financial report (10-K or IR), an earnings release (ER), or a management discussion (MDA). Since it is a general announcement released through the RNS system concerning company news (welcoming a government report and providing context on their product), and it doesn't fit the specific categories like DIRS, DIV, or CAP, the most appropriate classification is the general regulatory announcement category, RNS.
2019-10-16 English
Key appointments to further strengthen management
Board/Management Information Classification · 98% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory announcement from the London Stock Exchange's news service (RNS). The content explicitly announces 'key appointments to further strengthen management teams,' naming a new Chief Scientific Officer, Chief Commercial Officer, and Head of Investor Relations. This directly corresponds to the definition of Board/Management Information (MANG). Although it is distributed via RNS, the core subject matter is management appointments, making MANG the most specific classification. The document length (7051 chars) is substantial enough that it is not merely an announcement of an announcement (RPA/RNS), but the substantive content itself.
2019-09-23 English
Appointment of Joint Broker
Regulatory Filings Classification · 99% confidence The document begins with an 'RNS Number' and is dated September 20, 2019. The content announces the 'Appointment of Joint Broker' (finnCap Limited) and lists contact details for various financial advisors (Nominated Adviser, Joint Brokers). This type of announcement, which is a specific corporate action update distributed via the London Stock Exchange's RNS system, does not fit neatly into the defined categories like ER, 10-K, or MANG (which is specifically for board/management changes, not broker appointments). Since it is a general regulatory announcement distributed through RNS that doesn't match a more specific code, the most appropriate fallback category is Regulatory Filings (RNS). The document length is short (3464 chars), but it is a primary announcement, not an announcement *of* a report.
2019-09-20 English
EUR8.5m Credit Facility Secured
Regulatory Filings Classification · 98% confidence The document is identified by the header 'RNS Number : 0455N' and contains an announcement dated September 20, 2019, regarding Oncimmune Holdings PLC securing an €8.5m credit facility. This is a specific corporate action announcement concerning financing, which falls under the 'Capital/Financing Update' category. Although it is distributed via RNS, the content is specific enough to warrant the 'CAP' classification over the general 'RNS' fallback. The document is not a full report (like 10-K or IR) but a specific announcement of a financing event.
2019-09-20 English
Oncimmune to Present at 2019 CBIIC
Report Publication Announcement Classification · 99% confidence The document starts with an 'RNS Number' and is dated September 18, 2019. The content announces that Oncimmune Holdings plc will be presenting at a conference (CBIIC) and specifies when the presentation materials will be made available on their website. This is a general regulatory announcement regarding a future event and the subsequent availability of presentation materials, rather than the presentation itself, a formal financial report (like 10-K or IR), or a specific insider transaction. Given the structure (RNS Number, brief announcement format) and the nature of the information (announcement of participation in an external event), it fits best under the general regulatory announcement category, RNS.
2019-09-18 English
Positive Results for ECLS Trial Presentation
Regulatory Filings Classification · 99% confidence The document begins with an 'RNS Number' and is dated 09 September 2019. It announces positive results from a clinical trial (ECLS trial) regarding the company's EarlyCDT Lung test, which relates to cancer detection. The content is a press release detailing scientific/clinical validation and future steps, typical of a corporate announcement. Since it is distributed via RNS (London Stock Exchange news service) and reports on a significant development that isn't a standard periodic financial report (like 10-K or IR), it fits best under the general 'Regulatory Filings' category, which serves as a fallback for important, non-standard announcements distributed via official channels like RNS. It is not a Call Transcript (CT), Earnings Release (ER), or a formal financial report (10-K/IR).
2019-09-09 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.